Countries Australia
Axonics Receives Regulatory Approval for Recharge-Free SNM System in Australia
“Approval of the Axonics recharge-free system is welcome news for Australians with bladder and bowel dysfunction,” said...
May 17, 2024 | News
NeuShen Therapeutics Begins Phase I Trial of NS-136, a Potential Breakthrough in Schizophrenia Treatment
NeuShen Therapeutics , a clinical-stage global biotechnology company dedicated to pioneering treatments for neurological and psychiatric disorders, today a...
May 10, 2024 | News
Avance Clinical Expands Further into APAC with New Clinical Operations in South Korea
Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs, will attend BIO Korea (May 8-10, 2024) and formally open ...
May 08, 2024 | News
Alnylam and Medison Expand Global Partnership to Accelerate Access to Innovative Therapies
The expanded partnership will allow Alnylam and Medison to help accelerate access for patients in multiple regions under one glo...
May 01, 2024 | News
FDA Approves Ractigen Therapeutics' IND for Groundbreaking Bladder Cancer Therapy
Ractigen Therapeutics, a leader in the development of small activating RNA (saRNA) therapeutics, announced today that the U.S. Food and Drug Administration...
April 29, 2024 | News
Western Australia Boosts Biomedical Sector with Additional Funding for MTPConnect Training Programs
MTPConnect welcomes additional funding from the Western Australian Government to deliver critical industry training programs to boost the state’s bio...
April 22, 2024 | News
Actinogen Medical Launches Phase 2b XanaMIA Trial for Alzheimer's, Marks First Patient Treatment
Actinogen Medical Limited (ASX: ACW) announces that the first patient has been randomized and treated in the XanaMIA phase 2b clin...
April 16, 2024 | News
Cure Brain Cancer Foundation Launches Pioneering $575,000 Fellowship to Support Emerging Leaders in Brain Cancer Research
Cure Brain Cancer Foundation proudly unveiled the launch of its groundbreaking 5-Year Guardian Trust Early Career Fellowship, valued at $575,000. The...
April 08, 2024 | News
Ractigen Therapeutics Launches Pioneering Phase I Clinical Trial for Bladder Cancer with First Patient Dosed in Collaboration with GenesisCare
Ractigen Therapeutics, a pioneer in small activating RNA (saRNA) therapeutics, achieved a major milestone with the first patient dosed in its First-in-huma...
April 04, 2024 | News
Resonance Health Joins Forces with Micron, Inc. for Strategic Entry into Japan's Healthcare Sector
Resonance Health Ltd, listed on the Australian Securities Exchange (ASX) under the ticker RHT, has officially announced its strategic move into the Japanes...
March 28, 2024 | News
Alphamab Oncology Launches Groundbreaking Clinical Trial in Australia for Advanced Cancer Treatment
Alphamab Oncology (stock code: 9966.HK) announced that the first patient has been dosed in Australia in the clinical study (JSKN033-101) of JSKN0...
March 26, 2024 | News
Australia Grants AUD 17M to TB Alliance for Innovative Treatments
The Australian Government, through the Partnerships for a Healthy Region initiative, has announced a new AUD 17 million grant to support work with TB Allia...
March 25, 2024 | News
Antengene Advances ATG-022 in Phase II CLINCH Study for Solid Tumors in China and Australia,
Antengene Corporation Limited, a prominent global biopharmaceutical entity focused on the development and commercialization of pion...
March 21, 2024 | News
First Patient Treated in Phase 2 GvHD Trial
Cynata Therapeutics Limited (ASX: "CYP", "Cynata", or the "Company"), a clinical-stage biotechnology company specialising in cell therapeutics, c...
March 06, 2024 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
